Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bupropion: overview and prescribing guidelines in depression.

W A James1, S Lippmann

  • 1Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, KY.

Southern Medical Journal
|February 1, 1991
PubMed
Summary

Bupropion offers an effective alternative for major depression, including treatment-resistant and atypical depression. While generally well-tolerated with fewer cardiac risks than older drugs, it carries a risk of seizures, especially at higher doses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fabrication of shallow EUV gratings on silicon by irradiation with helium ions.

Nanotechnology·2025
Same author

Countering antimicrobial resistance.

Pulmonology·2025
Same author

Electric pulse heating device for the analysis of solid/solid phase transformations.

The Review of scientific instruments·2021
Same author

Results of 115 Rubis II reverse thumb carpometacarpal joint prostheses with a mean follow-up of 10 years.

The Journal of hand surgery, European volume·2017
Same author

[Recruitment for general practice - relationship between practice-based curriculum and career choice].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2013
Same author

Insomnia: therapeutic approach.

Southern medical journal·2001

Area of Science:

  • Pharmacology
  • Neuroscience
  • Clinical Medicine

Background:

  • Bupropion represents a novel antidepressant agent with a distinct chemical structure compared to existing medications.
  • Clinical trials indicate its efficacy in treating major depression is comparable to established antidepressant therapies.
  • It demonstrates utility in patient populations resistant to other treatments and those with atypical depression.

Framework:

  • Bupropion's unique pharmacological profile results in a significantly lower incidence of cardiac conduction issues and orthostatic hypotension compared to tricyclic antidepressants.
  • Minimal anticholinergic properties contribute to its favorable tolerability profile.
  • The primary reported side effect is dry mouth.

Implementation:

  • Bupropion's use requires careful consideration due to its potential to lower the seizure threshold.

Related Experiment Videos

  • It is contraindicated in individuals with a predisposition to seizures.
  • When administered at dosages of 450 mg/day or less, divided, the seizure risk in non-predisposed individuals is comparable to other antidepressants.

    • Implications:

    • Bupropion provides a valuable therapeutic option for major depressive disorder, offering an alternative with a different side effect profile.
    • Understanding its contraindications, particularly seizure risk, is crucial for safe and effective clinical application.
    • Further research may elucidate optimal dosing strategies to maximize efficacy while minimizing adverse events.